Benzimidavir. 1263W94, BW 1263W94, GW 1263.
D000818:Animals; D019380:Anti-HIV Agents / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D001682:Biological Availability; D002986:Clinical Trials as Topic; D003587:Cytomegalovirus / Q000187:drug effects; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000821:virology; D004352:Drug Resistance, Microbial; D015507:Drugs, Investigational / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D000882:Haplorhini; D006801:Humans; D051381:Rats; D012263:Ribonucleosides / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D004004:Dichlororibofuranosylbenzimidazole / Q000031:analogs & derivatives
D019380:Anti-HIV Agents; D001562:Benzimidazoles; D015507:Drugs, Investigational; D012263:Ribonucleosides; C400401:maribavir; D004004:Dichlororibofuranosylbenzimidazole